title: Pharmaceutical Approval Update.
abstract: Eluxadoline (Viberzi) for irritable bowel syndrome with diarrhea; tiotropium bromide/olodaterol inhalation spray (Stiolto Respimat) for chronic obstructive pulmonary disease; and sirolimus (Rapamune) for lymphangioleiomyomatosis.
authors.forename: Kunj
authors.initials: K
authors.lastname: Gohil